| Period Ending | Mar 30, 2013 | Dec 30, 2012 | Sep 29, 2012 | Jun 29, 2012 |
|---|
|
Total Revenue
|
20,842
|
19,308
|
18,861
|
18,339
| | Cost of Revenue |
-
|
-
|
-
|
-
| | |
Gross Profit
|
20,842
|
19,308
|
18,861
|
18,339
| |
|
Operating Expenses |
|
Research Development |
-
|
-
|
-
|
-
|
|
Selling General and Administrative | 11,417 | 9,844 | 9,453 | 9,928 |
|
Non Recurring |
-
|
-
|
-
|
-
|
|
Others |
-
|
-
|
-
|
-
|
|
|
|
Total Operating Expenses |
-
|
-
|
-
|
-
| | | |
Operating Income or Loss
|
9,425
|
9,468
|
9,408
|
8,411
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net | (172) | 182 | (1,213) | 129 |
|
Earnings Before Interest And Taxes | 9,253 | 9,680 | 8,169 | 8,540 |
|
Interest Expense |
-
| 4 |
-
|
-
|
|
Income Before Tax | 9,253 | 9,676 | 8,169 | 8,540 |
|
Income Tax Expense | (438) | 958 | (827) | 1,534 |
|
Minority Interest | (8,522) | (7,762) | (7,733) | (6,392) |
|
|
|
Net Income From Continuing Ops | 1,169 | 956 | 1,263 | 614 | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
-
|
-
|
|
Extraordinary Items |
-
|
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
|
-
| | | |
Net Income
|
1,169
|
956
|
1,263
|
614
| | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | |
Net Income Applicable To Common Shares
|
1,169
|
956
|
1,263
|
614
|
|
0.05(0.74%) 12:02PM EDT - Nasdaq Real Time Price